News

Bayer starts Phase III clinical development program OASIS with Elinzanetant

Bayer Inc. issues voluntary recall in Canada of specific TINACTIN® spray products due to the presence of benzene

Bayer selects 100 youth leaders from around the world to help “Feed a Hungry Planet” at the company’s 5th biennial Youth Ag Summit

Bayer is committed to working with cancer agencies and drug plans to bring innovative tumour agnostic treatment to Canadian patients

Bayer to advance two first-of-its-kind cell and gene therapies for Parkinson’s disease

Bayer brings “Feeding a Hungry Planet” into focus by inviting young leaders from Canada to apply for the 5th biennial Youth Ag Summit

Bayer’s finerenone meets primary endpoint in Phase III FIGARO-DKD cardiovascular outcomes study in patients with chronic kidney disease and type 2 diabetes